Funding Acknowledgements

Guidance on Acknowledgement of Support for Manuscripts Resulting from HPTN Funded Studies

Overall support for the HIV Prevention Trials Network (HPTN) is provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.

All publications and presentations must include a statement acknowledging the HPTN and NIH's support for the work and listing the applicable cooperative agreement numbers, unless the journal's policy precludes such an acknowledgment. Several of the suggested acknowledgements below require adding cooperative agreement numbers, contact co-authors to ensure all applicable cooperative agreements are acknowledged.. 

If other institutions at NIH provided additional funding and/or support for your study, an acknowledgement of that support is also required.  Contact your Project Officer at that institute for guidance.

If you have any questions regarding these acknowledgments or other concerns please contact hptn@fhi360.org.

 

For HPTN II and III funded studies under Award Number UM1 AI068619

Each publication, press release, or other document about research supported by an NIH award must include an acknowledgment of NIH award support and a disclaimer such as “Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number UM1AI068619. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” Prior to issuing a press release concerning the outcome of this research, please notify the NIH awarding IC in advance to allow for coordination.

 

For International studies funded by HPTN I and then transitioned to MTN or IMPAACT

This work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).

 

For U.S. Domestic studies funded by HIVNET and then by HPTN I, both networks should be acknowledged.

This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35173 with Family Health International; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with (name the sites). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations). 

 

For International studies funded by HIVNET and then by HPTN I, both networks should be acknowledged.

This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35173 with Family Health International; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with (name the sites). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).

 

For studies with both U.S. Domestic and International sites funded by HIVNET and then by HPTN, both networks should be acknowledged.

This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35176 with Abt Associates Inc.; contract N01-AI-35173 with Family Health International; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with name the sites). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).

 

For HIVNET 015, EXPLORE

This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Alcohol Abuse and Alcoholism (NIAAA), of the National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35176 with Abt Associates Inc.; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with (Denver Department of Health and Hospitals, Fenway Community Health Center, Howard Brown Health Center, New York Blood Center, Public Health Foundation, Inc.). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), and Office of AIDS Research (OAR), of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).